CEPI assists in the advancement, development and manufacture of COVID-19 vaccine
Bio E initiated a Phase 1/2 clinical trial to evaluate the vaccine candidate's safety and immunogenicity in India in November ...
Bio E initiated a Phase 1/2 clinical trial to evaluate the vaccine candidate's safety and immunogenicity in India in November ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily